Ellia Cytocare Private Limited
About Ellia Cytocare Private Limited
Data last updated:
Ellia Cytocare Private Limited is a private limited company based in Chauhan Patti, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC324558.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Kr Mishra and Reshma Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 54 G/F Kh. No. 27 & 28 Main 20 Ft. Ro Kaushal Puri, Chauhan Patti, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.12 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net profit of ₹1,916 (net margin 0.2%) and EBITDA of ₹1.07 Lakh (EBITDA margin 13.2%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ellia Cytocare Private Limited's registered office is in Chauhan Patti, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 54 G/F Kh. No. 27 & 28 Main 20 Ft. Ro Kaushal Puri, Chauhan Patti, Delhi, India – 110094
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ellia Cytocare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ellia Cytocare is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Administrative and support service activities | 82 | Office administrative, office support and other business support activities |
To see the full business activity and turnover split of Ellia Cytocare Private Limited, buy the company report.
Financials of Ellia Cytocare Private Limited
FY 2025 filings availableEllia Cytocare Private Limited reported revenue of ₹8.12 Lakh (down 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 51% fall in the latest year. EBITDA rose 361% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,916 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ellia Cytocare Private Limited, buy the company report.
Board of directors of Ellia Cytocare Private Limited
Ellia Cytocare has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kr Mishra Also directs: Florencia Healthcare Private Limited, Assurmed Pharmacy Private Limited, Perfecta Foodworks Private Limited and 1 more | Director | 05 Oct 2017 | 9 Years 0 Months | Current |
| Reshma Mishra Also directs: Florencia Healthcare Private Limited, Assurmed Pharmacy Private Limited, Perfecta Foodworks Private Limited and 1 more | Director | 05 Oct 2017 | 9 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Ellia Cytocare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ellia Cytocare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ellia Cytocare Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ellia Cytocare Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Reshma Mishra was appointed as Director on 05 Oct 2017.
Frequently asked questions
Ellia Cytocare is an active private limited company based in Chauhan Patti, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 October 2017 (9+ years old) and is registered under CIN U74999DL2017PTC324558.
Ellia Cytocare has 2 current directors:
- Sandeep Kr Mishra - Director
- Reshma Mishra - Director
The latest financial statements of Ellia Cytocare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Ellia Cytocare is U74999DL2017PTC324558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ellia Cytocare was incorporated on 05 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Reshma Mishra was appointed as Director on 05 Oct 2017. Sandeep Kr Mishra was appointed as Director on 05 Oct 2017.
The registered office of Ellia Cytocare is at A – 54 GF Kh. No. 27 & 28 Main 20 Ft. Ro Kaushal Puri, Chauhan Patti, Delhi, India – 110094.
Ellia Cytocare operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Ellia Cytocare is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Ellia Cytocare can be reached at its registered office: A – 54 GF Kh. No. 27 & 28 Main 20 Ft. Ro Kaushal Puri, Chauhan Patti, Delhi, India – 110094.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
